Erlotinib is produced by which regular pharmaceutical company and is introduced by the major global suppliers.

Erlotinib is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, mainly used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC) and pancreatic cancer. It blocks tumor cell proliferation and survival signals by inhibiting the EGFR signaling pathway, thereby delaying disease progression and improving patient survival and quality of life. This drug is widely used around the world and is one of the important drugs for targeted treatment of lung cancer.

In terms of production, the original drug of erlotinib is developed and produced by the Swiss pharmaceutical company Roche (Roche). The original brand name is Tarceva®. Roche Pharmaceuticals is an internationally renowned innovative pharmaceutical company with a complete R&D, production and global sales system to ensure the consistency of drug quality and clinical application. Original drugs have passed strict GMP production specifications and clinical trial verification to ensure that the drugs meet high standards in terms of efficacy and safety.

In addition to Roche's original drugs, the world's major supply manufacturers also have many generic drug companies. Pharmaceutical companies in India, Bangladesh, Brazil, Hong Kong, China and other regions have produced generic drugs of erlotinib. The drug ingredients are consistent with the original drug and the price is relatively low, providing more patients with an affordable choice. These generic drugs are usually supplied through international drug procurement channels or cross-border medical channels, and it is necessary to ensure that the sources are regular and the quality is reliable.

In terms of clinical use and drug purchase, patients should give priority to original drugs or certified generic drugs provided by regular manufacturers. Domestic patients can obtain it through large tertiary hospital pharmacies, international imported pharmacies or cross-border drug channels with import qualifications. When purchasing medicine, you should ensure that the packaging of the medicine is complete, the source is legal, and the medicine is used according to the doctor's prescription to ensure efficacy, safety and sustainable management of long-term medication.

Keyword tags: erlotinib, EGFR inhibitor, non-small cell lung cancer, long-term medication, safety

Reference:https://en.wikipedia.org/wiki/Erlotinib